gu
no way to compare when less than two revisions
Differences
This shows you the differences between two versions of the page.
— | gu [2017/07/07 18:30] (current) – created - external edit 127.0.0.1 | ||
---|---|---|---|
Line 1: | Line 1: | ||
+ | ====== Contrast Rxn ====== | ||
+ | {{reaction.jpg? | ||
+ | ====== Pelvis ====== | ||
+ | |||
+ | ===== Anatomy ===== | ||
+ | * Extraperitoneal cavity: contiguous with retroperitoneal space | ||
+ | * Retropubic space of Retzius: contiguous with posterior pararenal space + extraperitoneal fat | ||
+ | * Perineum: below pelvic diaphragm | ||
+ | * Parametrium: | ||
+ | * Denonvillier’s fascia: positioned between prostate and rectum | ||
+ | |||
+ | ====== Kidneys ====== | ||
+ | * Combination of coritcal & medullary nephrocalcinosis suggests primary oxaluria | ||
+ | ===== Grades of Vesicoureteral Reflux ===== | ||
+ | {{: | ||
+ | |||
+ | ===== Cortical Nephrocalcinosis (COAG) ===== | ||
+ | * Cortical Necrosis (Acute) | ||
+ | * Oxalosis | ||
+ | * Alport Syndrome | ||
+ | * Glomerulonephritis (Chronic) | ||
+ | |||
+ | ===== Medullary Nephrocalcinosis (MARCH) ===== | ||
+ | * Medullary Sponge Kidney | ||
+ | * Alkali Excess | ||
+ | * RTA (Type 1, Distal), Renal Medullary/ | ||
+ | * Chronic Glomerulonephritis | ||
+ | * Hyperoxaluria, | ||
+ | |||
+ | ===== Papillary Necrosis (POSTCARD) ===== | ||
+ | * Pyelonephritis | ||
+ | * Obstruction | ||
+ | * Sickle Cell | ||
+ | * TB/Trauma | ||
+ | * Cirrhosis | ||
+ | * Analgesic Nephropathy | ||
+ | * Renal Vein Thrombosis | ||
+ | * Diabetes | ||
+ | |||
+ | ===== Diffusely Hyperechoic Kidneys (HIV MAN) ===== | ||
+ | * HIV | ||
+ | * Inflammation | ||
+ | * Glomerulonephritis | ||
+ | * HTN, DM | ||
+ | * Vascular | ||
+ | * SLE / Vasculitis | ||
+ | * Multiple Myeloma | ||
+ | * Acute Tubular Necrosis / ARPCKD | ||
+ | * Nephrocalcinosis | ||
+ | |||
+ | * ESRD | ||
+ | * Hemolytic Uremic Syndrome | ||
+ | |||
+ | ===== Bilaterally Enlarged Kidneys (TIM VPC) ===== | ||
+ | * Tumor | ||
+ | * Leukemia / Lymphoma | ||
+ | * Myeloma | ||
+ | * Inflammation (acute) | ||
+ | * Glomerulonephritis | ||
+ | * Interstitial Nephritis | ||
+ | * ATN | ||
+ | * Metabolic | ||
+ | * Amyloid | ||
+ | * Diabetes | ||
+ | * Gaucher' | ||
+ | * Acromegaly | ||
+ | * Vascular | ||
+ | * Bilateral renal vein thrombosis | ||
+ | * Polycystic Kidney Disease | ||
+ | * Collagen Vascular Disease | ||
+ | |||
+ | ===== Bilaterally Small Kidneys (IR RAS) ===== | ||
+ | * Inflammation (chronic) | ||
+ | * Pyelo, Glomerulonephritis, | ||
+ | * Reflux (chronic infection) | ||
+ | * Bilateral renal artery stenosis | ||
+ | ===== Unilaterally Small Kidney (VOX HS) ===== | ||
+ | * Vascular (RAS / RVT) | ||
+ | * Obstruction | ||
+ | * XRT | ||
+ | * Hypoplasia | ||
+ | * Subcapsular hematoma (chronic) | ||
+ | |||
+ | ===== Urethral Stricture ===== | ||
+ | * iatrogenic | ||
+ | * post-infectious (gonococcal or non-gonococcal) | ||
+ | * non-infectious irritation (chemical or Reiter' | ||
+ | * traumatic injury | ||
+ | * neoplasm (long, irregular stricture ± fistula) | ||
+ | |||
+ | |||
+ | |||
+ | ===== Bosniak Classification ===== | ||
+ | * Category I - No atypical features | ||
+ | * US - anechoic without internal echoes, with good thru transmission and a barely perceptible but well defined wall | ||
+ | * CT - fluid density, no enhancement and imperceptible wall | ||
+ | * Category II - homogeneously hyperdense cyst that is not enhancing, or thin (<1mm) septations or thin wall Ca+ | ||
+ | * must be 3 cm or less in diameter, have one quarter of its wall extending outside the kidney so the wall can be assessed, and be nonenhancing after contrast material is administered | ||
+ | * Category IIF - minimally complicated cysts that need follow-up | ||
+ | * not well defined by Bosniak but consists of lesions that do not neatly fall into category II | ||
+ | * have some suspicious features that deserve follow-up up to detect any change in character. | ||
+ | * Category III - true indeterminate cystic masses that need surgical evaluation, although many prove to be benign | ||
+ | * thicker septations or multiloculated, | ||
+ | * may show uniform wall thickening, nodularity, thick or irregular peripheral calcification, | ||
+ | * hyperdense lesions that do not fulfill category II criteria are including in this group. | ||
+ | * Category IV - needs nephrectomy | ||
+ | * nonuniform or enhancing thick wall, enhancing or large nodules in the wall, or clearly solid components in the cystic lesion | ||
+ | * enhancement of at least 10 HU | ||
+ | |||
+ | ===== RCC Staging ===== | ||
+ | * Stage 1 -> confined by renal capsule (completely in kidney) | ||
+ | * Stage 2 -> beyond capsule but confined within Gerota’s fascia | ||
+ | * Stage 3A -> extension to renal vein or IVC | ||
+ | * Stage 3B -> positive lymph nodes | ||
+ | * Stage 3C -> both venous extension and adenopathy | ||
+ | * Stage 4A -> grows through gerotas fascia into adjacent organs (other than adrenal) | ||
+ | * Stage 4B -> distant mets | ||
+ | ===== Grading of Renal Lacerations ===== | ||
+ | FIXME | ||
+ | |||
+ | ====== Ureter & Bladder ====== | ||
+ | |||
+ | ===== DDx Small Bladder (CITRUS) ===== | ||
+ | * cystitis cystica | ||
+ | * interstitial cystitis | ||
+ | * TB | ||
+ | * rads | ||
+ | * unused bladder | ||
+ | * surgery and schistosomiasis | ||
+ | |||
+ | ===== DDx Pear-shaped Bladder (CILLI) ===== | ||
+ | * Collection - urinoma, hematoma, abscess | ||
+ | * IVC obstruction | ||
+ | * Lymphoma / adenopathy | ||
+ | * Lipomatosis | ||
+ | * Iliopsoas hypertrophy | ||
+ | |||
+ | |||
+ | ===== DDx for ureteral filling defects ===== | ||
+ | * Fungus ball | ||
+ | * Ureteritis cystica -> epithelial/ subepithelial cysts due to inflammation or irritation (metaplasia of Brunn’s nests) | ||
+ | * Clot | ||
+ | * Fibroepithelial polyp | ||
+ | * Endometriosis | ||
+ | * Stone / Sloughed papilla | ||
+ | * Tumor / TB | ||
+ | |||
+ | * Leukoplakia: | ||
+ | * Malakoplakia: | ||
+ | * looks like ureteritis cystica | ||
+ | |||
+ | ===== DDx hemorrhagic cystitis ===== | ||
+ | * viral and bacterial infection | ||
+ | * drugs - cyclophosphamide (cytoxan) | ||
+ | * eosinophilic | ||
+ | * cystitis cystica | ||
+ | |||
+ | ===== Pseudodiverticulosis ===== | ||
+ | * 1-3 mm outpouchings | ||
+ | * DDx -> calculi / infections / CA (#1 = TCC) | ||
+ | |||
+ | ===== Ureteral TCC ===== | ||
+ | * Risks: azo-dyes, cyclophosphamide, | ||
+ | * Radiographic: | ||
+ | * “Wine glass/ | ||
+ | * Bergman sign (coiled retrograde catheter) | ||
+ | ===== Ureteral displacement ===== | ||
+ | * Distribution: | ||
+ | |||
+ | ^ ^ **Medial** | ||
+ | |**Above Pelvis**|Retroperitoneal fibrosis\\ Retrocaval ureter \\ (right; at L3)|Psoas hypertrophy\\ LAD\\ AAA\\ Central tumor| | ||
+ | |**Below Pelvis**|Pelvic lipomatosis\\ Iliac LAD/ aneurysm\\ Iliopsoas hypertrophy\\ Hutch diverticulum|Fibroids\\ Ovarian masses| | ||
+ | |||
+ | * Medial | ||
+ | * Retroperitoneal fibrosis: drugs (methylsergide, | ||
+ | * Retrocaval ureter (right only) | ||
+ | * Pelvic lipomatosis: | ||
+ | * Other: hematoma; iliac LAD or aneurysms; adnexal mass; surgery | ||
+ | * Lateral: | ||
+ | * AAA | ||
+ | * LAD; psoas hypertrophy | ||
+ | * Central pelvic mass | ||
+ | * Retroperitoneal fat (≠ pelvic lipomatosis) | ||
+ | |||
+ | ===== DDx for ureteral stricture ===== | ||
+ | * Infection: TB; Schistosomiasis; | ||
+ | * CA: metastases; local extension; TCC; lymphoma | ||
+ | * XRT | ||
+ | * Inflammation: | ||
+ | ===== DDx for ureteral dilatation ===== | ||
+ | * Obstruction | ||
+ | * Reflux | ||
+ | * Primary megaureter (“beak” sign) | ||
+ | ===== DDx for bladder filling defects ===== | ||
+ | * Tumor: TCC; adenocarcinoma; | ||
+ | * Extrinsic masses: BPH; uterus (fibroids); etc. | ||
+ | * Other: calculus; thrombus; ureterocele (pseudoureterocele due to inflam/ tumor); foreign bodies | ||
+ | ===== Hutch Diverticulum ===== | ||
+ | * adjacent to UVJ; ↑ vesicoureteral reflux | ||
+ | ===== Bladder Carcinoma ===== | ||
+ | * Clinical: transitional cell (90% malignant); risks = azo-dyes; phenacetin; cyclophosphamide; | ||
+ | * Staging: | ||
+ | * Stage A: limited to mucosa + submucosa | ||
+ | * Stage B1: superficial muscular layer | ||
+ | * Stage B2: deep muscular layer | ||
+ | * Stage C: perivesical fat | ||
+ | * Stage D: seminal vesicles, prostate, or rectum | ||
+ | ===== Bladder Trauma ===== | ||
+ | * Contusion: interstitial | ||
+ | * Extraperitoneal: | ||
+ | * Intraperitoneal: | ||
+ | |||
+ | ===== DDx for Bladder Ca2+ (SCART) ===== | ||
+ | * Schistosomiasis (↑ squamous cell carcinoma) | ||
+ | * CA; cyclophosphamide (cytoxan); calculus | ||
+ | * Alkaline encrusting cystitis | ||
+ | * Radiation | ||
+ | * TB | ||
+ | |||
+ | ====== Urethra ====== | ||
+ | ===== Urethral Anatomy ===== | ||
+ | |||
+ | ==== Anatomy (male) ==== | ||
+ | * Anterior = penile + bulbous (penoscrotal junction) | ||
+ | * Posterior = membranous (between inferior margin of verumontanum + tip/ cone of bulbous urethra) + prostatic | ||
+ | * Cowper’s glands: contained within membranous urethra with ducts entering the bulbous urethra | ||
+ | * Glands of Littré: located primarily along dorsal penile urethra → infections (gonococcus; | ||
+ | |||
+ | {{urethra.png}} | ||
+ | |||
+ | ===== Urethral Injuries ===== | ||
+ | * Clinical: risks = pelvic trauma (especially multiple pelvic fractures); absence of blood at meatus does not exclude urethral injury → RUG | ||
+ | * Subtypes: | ||
+ | * Type I: posterior urethra stretched | ||
+ | * Type II: posterior disruption (above urogenital diaphragm) | ||
+ | * Type III: anterior + posterior disruption | ||
+ | * Type IV: bladder neck injury with extension to urethra | ||
+ | * Type IVa: periurethral extravasation with intact urethra | ||
+ | * Type V: anterior disruption (“saddle” injury); ↑ bulbous urethra | ||
+ | ===== Female Urethral Diverticulum ===== | ||
+ | * Clinical: most often acquired due to infection of Skene’s glands; ↑ posterior wall; SXS = dysuria + dribbling + dyspareunia (3 D’s); | ||
+ | TX = surgical resection (diverticulectomy) | ||
+ | * Radiographic: | ||
+ | * Complications: | ||
+ | ===== DDx for Urethral Strictures (TIICB) ===== | ||
+ | * Trauma | ||
+ | * Inflammatory; | ||
+ | * Calculus | ||
+ | * BXO (= balanitis xerotica obliterans): | ||
+ | ===== Hypospadias ===== | ||
+ | * ↑ cryptorchidism (30%) + inguinal hernias (10%) | ||
+ | ===== DDx for Urethral Tumors ===== | ||
+ | ==== Benign ==== | ||
+ | * Fibroepithelial polyp: solitary; pedunculated; | ||
+ | * Transitional cell papilloma: ↑ prostatic/ bulbomembranous urethra; ↑ bladder papillomas; older adults | ||
+ | * Adenomatous polyp: ↑ young men; adjacent to veru montanum | ||
+ | * Penile squamous papilloma / condyloma acuminata: verrucous lesion in penile urethra; associated with cutaneous disease | ||
+ | |||
+ | ==== Malignant ==== | ||
+ | * Squamous cell carcinoma (70%): distal 2/3 of urethra; risks = venereal disease; ↑ stricture (> 80%) | ||
+ | * TCC (10-20%): posterior 1/3 of urethra; ↑ multifocal | ||
+ | * Adenocarcinoma (10-20%): arise from periurethral glands (Skene; female) and glands of Cowper/ Littré (male) | ||
+ | |||
+ | |||
+ | |||
+ | ====== Testes ====== | ||
+ | |||
+ | ===== Testicular Cancer ===== | ||
+ | * Clinical: seminomas → orchiectomy + XRT; nonseminomas (radioresistant) → orchiectomy + chemotherapy | ||
+ | * Staging: | ||
+ | * Stage I: limited to testes and spermatic cord | ||
+ | * Stage II: lymph nodes below the diaphragm | ||
+ | * Stage III: lymph nodes above the diaphragm | ||
+ | * A: lymph nodes only | ||
+ | * B: extranodal mets | ||
+ | * Lymphatic spread: along gonadal veins → renal hilar nodes; external iliac nodes → para-aortic nodes | ||
+ | * Hematogenous spread: uncommon except for choriocarcinoma | ||
+ | * Cryptorchidism: | ||
+ | ===== Extratesticular Mass DDx ===== | ||
+ | * Inguinal hernia | ||
+ | * Inflammatory mass such as infection, sarcoidosis | ||
+ | * Benign neoplastic processes such as adenomatoid tumor, epidermoid inclusion cyst | ||
+ | * Malignant processes such as soft tissue sarcomas, mesothelioma of the tunica, lymphoma, and metastatic disease. | ||
+ | |||
+ | ===== Peyronie' | ||
+ | * Calcification of tunica albuginea of corpora cavernosa | ||
+ | * Idiopathic, older men (> 45 yrs old) | ||
+ | |||
+ | ====== Prostate ====== | ||
+ | ===== Anatomy ===== | ||
+ | * U/S → hyperechoic central gland = transitional + central zones | ||
+ | * Transition zone (5%): periurethral → BPH | ||
+ | * Central zone (25%): ejaculatory ducts | ||
+ | * Peripheral zone (75%): carcinoma (> 80%); hypoechoic | ||
+ | ===== BPH ===== | ||
+ | * periurethral transitional zone; enlarged, lobulated gland; cystic degeneration; | ||
+ | ===== Prostatic Cysts ===== | ||
+ | * Midline: | ||
+ | * Mullerian duct: larger; extend superiorly | ||
+ | * Utricular cyst: smaller; communicate with urethra; ↑ hypospadias | ||
+ | * Ejaculatory duct cyst: acquired; due to obstruction | ||
+ | * Eccentric: | ||
+ | * Cystic prostatitis/ | ||
+ | * Cystic BPH | ||
+ | * DDX = seminal vesicle cysts → unilateral; ↑ ipsilateral renal agenesis (= Zinner syndrome) > cystic renal disease (APKD), renal ectopia, duplication, | ||
+ | |||
+ | ===== Prostate Carcinoma ===== | ||
+ | * Clinical: # 2 male CA; enlarged gland with nodules; periprostatic stranding; regional nodes; direct extension to seminal vesicles, bladder; mets to axial skeleton | ||
+ | * Radiographic: | ||
+ | ==== Staging ==== | ||
+ | * Stage A: nonpalpable | ||
+ | * Stage B: confined to prostate | ||
+ | * Stage C: capsular involvement | ||
+ | * 1: invasion | ||
+ | * 2: penetration | ||
+ | * 3: seminal vesicles | ||
+ | * Stage D: metastases | ||
+ | * D1: pelvic LN | ||
+ | * D2: bone; distant LN | ||
+ | * Treatment: Stage A/B → radical prostatectomy +/- XRT; Stage C/D → hormone therapy +/- XRT | ||
+ | |||
+ | ====== Peritoneal Cavity, Vessels, and Nodes ====== | ||
+ | ===== Fluid in peritoneal cavity ===== | ||
+ | * Ascites: serous; due to CHF, cirrhosis, hypoproteinemia, | ||
+ | * Exudative ascites: pancreattis → accumulates within lesser sac; peritonitis; | ||
+ | * Hemoperitoneum: | ||
+ | * Pseudomyxoma peritonei: due to appendiceal mucocele or mucinous cystadenocarcinoma of the ovary (> urachal/ endometrial CA); peritoneum filled with gelatinous mucin; Ca2+ | ||
+ | ===== Pneumoperitoneum ===== | ||
+ | * due to bowel perforation, | ||
+ | ===== Peritoneal tumors ===== | ||
+ | * Peritoneal carcinomatosis: | ||
+ | * Etiologies: ovarian, pancreatic, gastric, and colon carcinoma | ||
+ | * Radiographic: | ||
+ | * Peritoneal (cystic) mesothelioma: | ||
+ | * Mesenteric lipodystrophy (= retractile mesenteritis): | ||
+ | ===== Abscess ===== | ||
+ | * Clinical: complications of trauma or surgery; pancreatitis; | ||
+ | * Radiographic: | ||
+ | ===== DDx for cystic abdominal masses ===== | ||
+ | * Abscess | ||
+ | * Loculated ascites | ||
+ | * Pancreatic pseudocyst | ||
+ | * Ovarian cyst/ tumor | ||
+ | * Cystic teratoma: fat, water, Ca< | ||
+ | * Enteric duplication cysts: lined by GI mucosa | ||
+ | * Lymphocele: complication of surgery / trauma | ||
+ | * Cystic lymphangioma: | ||
+ | ===== DDx for pelvic cystic masses ===== | ||
+ | * Ectopic pregnancy: adnexal/ tubal ring | ||
+ | * TOA: tubo-ovarian abscess | ||
+ | * Endometrioma | ||
+ | * Ovarian neoplasms | ||
+ | * Ovarian cysts | ||
+ | * Extra-GU origin: abscess; urinoma; duplication/ | ||
+ | ===== Lymph nodes ===== | ||
+ | * Pathology: lymphadenopathy: | ||
+ | * Hodgkin’s lymphoma: 40% of total; contiguous spread | ||
+ | * Non-Hodgkin’s lymphoma: 60% of total; noncontiguous spread; ↑ GI involvement | ||
+ | ===== DDx for hypodense intra-abdominal/ | ||
+ | * Infection: MAI > TB (↑ AIDS), histoplasmosis | ||
+ | * Whipple’s disease: glycogen deposition | ||
+ | * Tumors: lymphoma (post-therapy); | ||
+ | ===== Trauma ===== | ||
+ | * Hemoperitoneum: | ||
+ | * Pneumoperitoneum: | ||
+ | * Subcapsular hematomas: crescentic → flatten parenchyma | ||
+ | * Lacerations: | ||
+ | * Intraparenchymal hematomas: rounded, low density areas | ||
+ | ====== Retroperitoneum ====== | ||
+ | ===== Retroperitoneal fibrosis ===== | ||
+ | * ST-encasement of retroperitoneal vessels/ ureters without anterior displacement (DDX = lymphoma); prominent enhancement | ||
+ | * Drugs: methylsergide; | ||
+ | * Lymphoma | ||
+ | * Metastases: lung; breast; carcinoid | ||
+ | * Other: AAA; trauma; surgery; instrumentation | ||
+ | * Ormond’s disease: idiopathic | ||
+ | ===== DDx for retroperitoneal masses ===== | ||
+ | ==== Malignant ==== | ||
+ | * MFH (#1) | ||
+ | * Liposarcoma (#2) | ||
+ | * Other: leiomyosarcoma; | ||
+ | ==== Benign ==== | ||
+ | * XGP | ||
+ | * Neural tumors | ||
+ | * Lymphangioma; | ||
+ | * Teratoma (dermoid) | ||
+ | ===== Retroperitoneal Fibrosis ===== | ||
+ | * Associated w/ | ||
+ | * aortic aneurysms | ||
+ | * inflammatory bowel dz | ||
+ | * urinomas | ||
+ | * retroperitoneal hematomas | ||
+ | * aortic and iliac graft procedures | ||
+ | * infections | ||
+ | * ergot alkaloids | ||
+ | * sclerosing cholangitis | ||
+ | * fibrosing mediastinitis | ||
+ | ===== Waterhouse-Friderichsen syndrome ===== | ||
+ | * massive, usually bilateral, hemorrhage into the adrenal glands caused by fulminant meningococcemia | ||
+ | ===== Low-density Retroperitoneal Nodes ===== | ||
+ | * Neoplastic | ||
+ | * Testicular (particularly teratocarcinoma) | ||
+ | * Epidermoid carcinoma of GU tract | ||
+ | * Lymphoma | ||
+ | * Leiomyosarcoma | ||
+ | * Infectious | ||
+ | * Whipple' | ||
+ | * MAI |
gu.txt · Last modified: 2017/07/07 18:30 by 127.0.0.1